Expand ALKS Menu
ALKS MENU

ALKS Latest Press Releases

-- April 17, 2024 --

Alkermes to Report First Quarter Financial Results on May 1, 2024 PRNewswire 4:00 PM

-- April 9, 2024 --

Alkermes Announces Positive Topline Results From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients With Narcolepsy Type 2 and Idiopathic Hypersomnia PRNewswire 7:00 AM

-- April 8, 2024 --

Alkermes Presents Analyses From Long-Term Safety Study of LYBALVI (olanzapine and samidorphan) at 2024 Congress of the Schizophrenia International Research Society PRNewswire 7:00 AM

-- March 7, 2024 --

Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors PRNewswire 7:00 AM

-- February 15, 2024 --

Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2023 and Provides Financial Expectations for 2024 PRNewswire 7:00 AM

-- February 8, 2024 --

Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 15, 2024 PRNewswire 4:00 PM

-- January 3, 2024 --

Alkermes to Present at the 42nd Annual J.P. Morgan Healthcare Conference PRNewswire 4:00 PM
Alkermes Announces Topline Results From Long-Term, Open-Label Safety and Durability of Treatment Effect Study of LYBALVI (olanzapine and samidorphan) PRNewswire 7:00 AM

-- December 14, 2023 --

Alkermes plc Announces Agreement to Sell Athlone, Ireland Facility to Novo Nordisk PRNewswire 6:05 AM

-- December 1, 2023 --

Uber Technologies, Jabil and Builders FirstSource Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 PRNewswire 6:16 PM